| NCT06834568 | Tandem Freedom - Feasibility Trial 2 | COMPLETED | NA | 2025-03-24 | 2025-04-07 | 2025-04-07 |
| NCT05973422 | Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes | NOT_YET_RECRUITING | NA | 2024-05-31 | 2024-09-30 | 2024-09-30 |
| NCT06428591 | Tandem Freedom - Feasibility Trial 1 | COMPLETED | NA | 2024-05-29 | 2024-06-10 | 2024-06-10 |
| NCT06273124 | Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes | COMPLETED | NA | 2024-03-07 | 2024-12-11 | 2024-12-11 |
| NCT05785832 | A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes | COMPLETED | NA | 2023-06-01 | 2024-09-24 | 2024-09-24 |
| NCT05683392 | Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes | COMPLETED | NA | 2023-02-01 | 2023-12-13 | 2023-12-13 |
| NCT05403502 | Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes | COMPLETED | NA | 2022-08-31 | 2023-08-02 | 2023-08-02 |
| NCT05422053 | Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ) | COMPLETED | NA | 2022-06-29 | 2023-01-06 | 2023-01-06 |
| NCT05204134 | Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use | COMPLETED | NA | 2022-03-24 | 2022-09-29 | 2022-09-09 |
| NCT05111301 | Control-IQ Technology in Individuals With Type 2 Diabetes | COMPLETED | NA | 2021-11-30 | 2022-08-18 | 2022-08-10 |
| NCT05014789 | Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study | COMPLETED | NA | 2021-08-19 | 2021-12-20 | 2021-12-20 |
| NCT03195140 | Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial | COMPLETED | NA | 2017-08-11 | 2018-02-06 | 2018-02-06 |
| NCT02877771 | Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study | COMPLETED | PHASE1 | 2016-08 | 2016-08 | 2016-08 |